Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 3, 2019 Off

SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for the Treatment of a Severe Form of Neurofibromatosis Type 1

By BusinessWire

STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…

June 3, 2019 Off

Epizyme Reports Updated Data from Phase 2 Trial of Tazemetostat for Epithelioid Sarcoma at 2019 ASCO Annual Meeting

By BusinessWire

New Clinical Data Presented Today Included in Recently Submitted NDA to FDA CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage…

June 3, 2019 Off

Massive Bio Partners with Biden Cancer Initiative to Improve Access to Oncology Clinical Trials

By BusinessWire

NEW YORK–(BUSINESS WIRE)–#ChildhoodCancerAwareness–Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership…

June 3, 2019 Off

Avacta Group plc TMAC Programme Accelerates: Clinical Trial Planned for Early 2020

By BusinessWire

Key linker element of Avacta’s novel TMAC™ drug conjugate to be tested in humans within 12 months CAMBRIDGE, England–(BUSINESS WIRE)–Avacta…

June 3, 2019 Off

LEO Pharma appoints Catherine Mazzacco as new CEO

By BusinessWire

BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma, a global leader in medical dermatology, today announced that Gitte Aabo will step down as President…

June 3, 2019 Off

Great Bay Bio was Founded to Build a Platform for CMC Technology and Pre-Clinical Research and Development of Big Data Services for Innovative Drugs, Dr. Michael Chan as CEO

By BusinessWire

HONG KONG–(BUSINESS WIRE)–Great Bay Bio, a leading biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical…

June 3, 2019 Off

Qkine Secures Additional £550K to Extend Development of R&D Pipeline and Accelerate Commercialisation of Product Portfolio

By BusinessWire

CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge–Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications has closed a further round…

June 3, 2019 Off

New Biomarker Research Builds Further Understanding of Tebentafusp (IMCgp100) Mechanism of Action, Link to Clinical Activity in Advanced Melanoma

By BusinessWire

New analyses from first-in-human clinical trial presented at the 2019 ASCO Annual Meeting Pivotal trials in metastatic uveal melanoma are…

June 3, 2019 Off

Final Progression-Free Survival Data and the Second Interim Analysis of Overall Survival from the J-ALEX Study for Alecensa Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

By BusinessWire

Alecensa reduced the risk of disease progression or death by 63% compared to crizotinib Long-term follow-up reconfirmed that Alecensa prolonged…

June 3, 2019 Off

New Data from GEOMETRY mono-1 Study Show Clinically Meaningful Results in Patients with Non-Small Cell Lung Cancer with MET exon-14 Skipping Mutation Treated with Capmatinib

By BusinessWire

Primary efficacy analysis demonstrated promising efficacy for capmatinib irrespective of the prior line of therapy in 97 patients: overall response…

Posts pagination

Previous 1 … 3,142 3,143 3,144 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine